South Korea
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.84 B
|
Dec. 31, 2023 | USD 698.37 | 1.93% |
|
South Korea |
|
2 |
USD 2.40 B
|
Dec. 31, 2023 | USD 1.83 | 0.74% |
|
South Korea |
|
3 |
USD 1.67 B
|
Dec. 31, 2023 | USD 125.83 | 1.12% |
|
South Korea |
|
4 |
USD 1.58 B
|
Dec. 31, 2023 | USD 10.34 | -1.02% |
|
South Korea |
|
5 |
USD 1.43 B
|
Dec. 31, 2023 | USD 89.21 | -4.31% |
|
South Korea |
|
6 |
USD 1.39 B
|
Dec. 31, 2023 | USD 13.98 | -3.04% |
|
South Korea |
|
7 |
USD 1.28 B
|
Dec. 31, 2023 | USD 64.45 | 0.31% |
|
South Korea |
|
8 |
USD 1.25 B
|
Dec. 31, 2023 | USD 108.37 | -2.33% |
|
South Korea |
|
9 |
USD 1.16 B
|
Dec. 31, 2023 | USD 3.84 | 0.74% |
|
South Korea |
|
10 |
USD 1.15 B
|
Dec. 31, 2023 | USD 177.66 | 0.74% |
|
South Korea |
|
11 |
USD 1.06 B
|
Dec. 31, 2023 | USD 89.82 | -0.84% |
|
South Korea |
|
12 |
USD 958.39 M
|
Dec. 31, 2023 | USD 19.95 | 0.05% |
|
South Korea |
|
13 |
USD 869.38 M
|
Dec. 31, 2023 | USD 68.20 | 0.14% |
|
South Korea |
|
14 |
USD 732.63 M
|
Dec. 31, 2023 | USD 7.70 | -1.01% |
|
South Korea |
|
15 |
USD 712.76 M
|
Dec. 31, 2023 | USD 2.05 | 0.07% |
|
South Korea |
|
16 |
USD 675.67 M
|
Dec. 31, 2023 | USD 32.09 | 0.74% |
|
South Korea |
|
17 |
USD 660.19 M
|
Dec. 31, 2023 | USD 7.02 | 1.13% |
|
South Korea |
|
18 |
USD 617.51 M
|
Dec. 31, 2023 | USD 5.50 | 0.24% |
|
South Korea |
|
19 |
USD 582.44 M
|
Dec. 31, 2023 | USD 26.36 | -7.63% |
|
South Korea |
|
20 |
USD 574.87 M
|
Dec. 31, 2023 | USD 16.03 | -1.15% |
|
South Korea |
|
21 |
USD 561.40 M
|
Dec. 31, 2023 | USD 10.59 | -0.10% |
|
South Korea |
|
22 |
USD 509.94 M
|
Dec. 31, 2023 | USD 36.83 | -2.69% |
|
South Korea |
|
23 |
USD 503.56 M
|
Dec. 31, 2023 | USD 7.85 | -1.23% |
|
South Korea |
|
24 |
USD 490.33 M
|
Dec. 31, 2023 | USD 4.71 | 1.18% |
|
South Korea |
|
25 |
USD 461.38 M
|
Dec. 31, 2023 | USD 8.18 | 0.99% |
|
South Korea |
|
26 |
USD 456.63 M
|
Dec. 31, 2023 | USD 9.53 | 1.69% |
|
South Korea |
|
27 |
USD 404.70 M
|
Dec. 31, 2023 | USD 10.03 | -2.25% |
|
South Korea |
|
28 |
USD 401.47 M
|
Dec. 31, 2023 | USD 8.46 | 0.09% |
|
South Korea |
|
29 |
USD 298.59 M
|
Dec. 31, 2023 | USD 38.12 | 0.02% |
|
South Korea |
|
30 |
USD 295.64 M
|
Dec. 31, 2023 | USD 13.23 | 1.89% |
|
South Korea |
|
31 |
USD 283.78 M
|
Dec. 31, 2023 | USD 33.55 | -1.07% |
|
South Korea |
|
32 |
USD 282.14 M
|
Dec. 31, 2023 | USD 17.02 | -2.20% |
|
South Korea |
|
33 |
USD 277.33 M
|
Dec. 31, 2023 | USD 4.37 | 0.43% |
|
South Korea |
|
34 |
USD 273.29 M
|
Dec. 31, 2023 | USD 11.90 | 21.74% |
|
South Korea |
|
35 |
USD 272.56 M
|
Dec. 31, 2023 | USD 75.63 | -3.02% |
|
South Korea |
|
36 |
USD 224.35 M
|
Dec. 31, 2023 | USD 11.90 | 0.22% |
|
South Korea |
|
37 |
USD 218.87 M
|
Dec. 31, 2023 | USD 61.65 | 0.74% |
|
South Korea |
|
38 |
USD 203.61 M
|
Dec. 31, 2023 | USD 10.90 | 0.42% |
|
South Korea |
|
39 |
USD 202.17 M
|
Dec. 31, 2023 | USD 12.88 | 0.37% |
|
South Korea |
|
40 |
USD 200.46 M
|
Dec. 31, 2023 | USD 171.86 | 2.57% |
|
South Korea |
|
41 |
USD 198.94 M
|
Dec. 31, 2023 | USD 8.31 | 1.99% |
|
South Korea |
|
42 |
USD 180.41 M
|
Dec. 31, 2023 | USD 1.45 | 1.70% |
|
South Korea |
|
43 |
USD 176.94 M
|
Dec. 31, 2023 | USD 8.29 | 0.57% |
|
South Korea |
|
44 |
USD 169.82 M
|
Dec. 31, 2023 | USD 83.61 | 0.82% |
|
South Korea |
|
45 |
USD 169.15 M
|
Dec. 31, 2023 | USD 14.32 | 2.94% |
|
South Korea |
|
46 |
USD 158.87 M
|
Dec. 31, 2023 | USD 7.40 | 0.83% |
|
South Korea |
|
47 |
USD 153.78 M
|
Dec. 31, 2023 | USD 7.51 | 2.04% |
|
South Korea |
|
48 |
USD 150.79 M
|
Dec. 31, 2023 | USD 9.49 | 2.21% |
|
South Korea |
|
49 |
USD 130.83 M
|
Dec. 31, 2023 | USD 16.27 | 0.32% |
|
South Korea |
|
50 |
USD 130.23 M
|
Dec. 31, 2023 | USD 1.26 | 0.79% |
|
South Korea |
The Health Care company in South Korea with the highest Revenue is Samsung Biologics Co.,Ltd. (KSE: 207940.KS) at USD 2.84 B.
The Health Care company in South Korea with the lowest Revenue is MedPacto, Inc. (KOSDAQ: 235980.KQ) at USD 0.00.
The top 10 Health Care companies in South Korea by Revenue are Samsung Biologics Co.,Ltd., EASY HOLDINGS Co., Ltd., Celltrion, Inc., Green Cross Holdings Corporation, Yuhan Corporation, Daewoong Co., Ltd., Chong Kun Dang Pharmaceutical Corp., Green Cross Corporation, Kwang Dong Pharmaceutical Co., Ltd. and Hanmi Pharm. Co., Ltd..
The bottom 10 Health Care companies in South Korea by Revenue are MedPacto, Inc., Cellid, Co., Ltd., Gencurix Inc., Peptron, Inc., SillaJen, Inc., Helixmith Co., Ltd, Genexine, Inc., CrystalGenomics, Inc., Oscotec Inc. and Anterogen.Co.,Ltd..